These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30844538)

  • 21. Mechanism of Enhanced Immature Dengue Virus Attachment to Endosomal Membrane Induced by prM Antibody.
    Wirawan M; Fibriansah G; Marzinek JK; Lim XX; Ng TS; Sim AYL; Zhang Q; Kostyuchenko VA; Shi J; Smith SA; Verma CS; Anand G; Crowe JE; Bond PJ; Lok SM
    Structure; 2019 Feb; 27(2):253-267.e8. PubMed ID: 30471923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autophagy facilitates antibody-enhanced dengue virus infection in human pre-basophil/mast cells.
    Fang YT; Wan SW; Lu YT; Yao JH; Lin CF; Hsu LJ; Brown MG; Marshall JS; Anderson R; Lin YS
    PLoS One; 2014; 9(10):e110655. PubMed ID: 25329914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection.
    Pinto AK; Brien JD; Lam CY; Johnson S; Chiang C; Hiscott J; Sarathy VV; Barrett AD; Shresta S; Diamond MS
    mBio; 2015 Sep; 6(5):e01316-15. PubMed ID: 26374123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphological Diversity and Dynamics of Dengue Virus Affecting Antigenicity.
    Fibriansah G; Lim XN; Lok SM
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies.
    Tsai WY; Durbin A; Tsai JJ; Hsieh SC; Whitehead S; Wang WK
    J Virol; 2015 Jul; 89(14):7348-62. PubMed ID: 25972550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody-dependent enhancement of dengue virus infection in vitro by undiluted sera from monkeys infected with heterotypic dengue virus.
    Ito M; Mukai RZ; Takasaki T; Kotaki A; Kurane I
    Arch Virol; 2010 Oct; 155(10):1617-24. PubMed ID: 20644969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A human bispecific neutralization antibody against four serotypes of dengue virus.
    Wang R; Lu J; Chen L; Yu Y; Yang Z
    Virology; 2021 Jun; 558():49-56. PubMed ID: 33721729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies.
    Poddar A; Ramasamy V; Shukla R; Rajpoot RK; Arora U; Jain SK; Swaminathan S; Khanna N
    BMC Biotechnol; 2016 Jun; 16(1):50. PubMed ID: 27301568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dengue virus antibody database: Systematically linking serotype-specificity with epitope mapping in dengue virus.
    Chaudhury S; Gromowski GD; Ripoll DR; Khavrutskii IV; Desai V; Wallqvist A
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005395. PubMed ID: 28222130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and characterization of a linearized B-cell epitope on the pr protein of dengue virus.
    Song KY; Zhao H; Li SH; Li XF; Deng YQ; Wang HJ; Ye Q; Zhu SY; Jiang ZY; Zhang FC; Qin ED; Qin CF
    J Gen Virol; 2013 Jul; 94(Pt 7):1510-1516. PubMed ID: 23559476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A fusion-loop antibody enhances the infectious properties of immature flavivirus particles.
    Rodenhuis-Zybert IA; Moesker B; da Silva Voorham JM; van der Ende-Metselaar H; Diamond MS; Wilschut J; Smit JM
    J Virol; 2011 Nov; 85(22):11800-8. PubMed ID: 21880758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expression profile of human peripheral blood mononuclear cell miRNA is altered by antibody-dependent enhancement of infection with dengue virus serotype 3.
    Jiang L; Sun Q
    Virol J; 2018 Mar; 15(1):50. PubMed ID: 29566761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of Autophagy-Mediated Dengue Virus Antibody-Dependent Enhancement Infection of THP-1 Cells.
    Jiang L; Sun Q
    Intervirology; 2020; 63(1-6):57-65. PubMed ID: 33202415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody-independent and dependent infection of human myeloid cells with dengue virus is inhibited by carrageenan.
    Piccini LE; Carro AC; Quintana VM; Damonte EB
    Virus Res; 2020 Dec; 290():198150. PubMed ID: 32866533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention.
    Goncalvez AP; Engle RE; St Claire M; Purcell RH; Lai CJ
    Proc Natl Acad Sci U S A; 2007 May; 104(22):9422-7. PubMed ID: 17517625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults.
    Saito Y; Moi ML; Takeshita N; Lim CK; Shiba H; Hosono K; Saijo M; Kurane I; Takasaki T
    BMC Infect Dis; 2016 Oct; 16(1):578. PubMed ID: 27756212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dengue immune sera enhance Zika virus infection in human peripheral blood monocytes through Fc gamma receptors.
    Li M; Zhao L; Zhang C; Wang X; Hong W; Sun J; Liu R; Yu L; Wang J; Zhang F; Jin X
    PLoS One; 2018; 13(7):e0200478. PubMed ID: 30044839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation and analysis of dengue virus enhancing and neutralizing activities using simple high-throughput assays.
    Li XQ; Chen J; Huang YF; Ding XX; Liu LD; Qiu LW; Pan YX; Deng YQ; Hu DM; Di B; Qin CF; Che XY
    Appl Microbiol Biotechnol; 2013 Jul; 97(14):6503-11. PubMed ID: 23760532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pseudo-infectious reporter virus particles for measuring antibody-mediated neutralization and enhancement of dengue virus infection.
    Mukherjee S; Pierson TC; Dowd KA
    Methods Mol Biol; 2014; 1138():75-97. PubMed ID: 24696332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zika convalescent macaques display delayed induction of anamnestic cross-neutralizing antibody responses after dengue infection.
    Valiant WG; Huang YS; Vanlandingham DL; Higgs S; Lewis MG; Mattapallil JJ
    Emerg Microbes Infect; 2018 Jul; 7(1):130. PubMed ID: 30006514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.